Voyageur Pharmaceuticals Ltd. (TSXV:VM)
Canada · Delayed Price · Currency is CAD 0.1200
0.00 (0.00%)
Apr 10, 2026, 12:50 PM EST
Voyageur Pharmaceuticals Revenue
In the fiscal year ending November 30, 2025, Voyageur Pharmaceuticals had annual revenue of 11.69K CAD. Voyageur Pharmaceuticals had revenue of 645.00 in the quarter ending November 30, 2025.
Revenue
11.69K
Revenue Growth
n/a
P/S Ratio
1,834.01
Revenue / Employee
n/a
Employees
n/a
Market Cap
21.43M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Nov 30, 2025 | 11.69K | - | - |
| Nov 30, 2024 | - | - | - |
| Nov 30, 2023 | - | - | - |
| Nov 30, 2022 | - | - | - |
| Nov 30, 2021 | - | - | - |
| Nov 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Nov 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Nov 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Nov 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Nov 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Ayr Wellness | 650.97M |
| 1CM Inc. | 75.01M |
| Rubicon Organics | 59.45M |
| MediPharm Labs | 45.12M |
| Avicanna | 25.48M |
| Crescita Therapeutics | 21.12M |
| Greenway Greenhouse Cannabis | 9.13M |
| Optimi Health | 193.60K |
Voyageur Pharmaceuticals News
- 17 days ago - Voyageur Announces Non-Brokered Life Offering - TheNewswire
- 26 days ago - Voyageur Announces Advancements on its Barium & Iodine Contrast Media Projects - TheNewswire
- 5 weeks ago - Voyageur Pharmaceuticals Confirms Pharmaceutical-Grade Purity of Barite from Frances Creek and Progresses to Health Canada Human Trial with Alberta Innovates Grant; Announces Stock Option and DSU grants, and Proposed Issuance of Securities for Debt - TheNewswire
- 6 weeks ago - Voyageur Pharmaceuticals Announces Collaboration with Bayer - TheNewswire
- 3 months ago - Voyageur Pharmaceuticals Strengthens Scientific Team by Adding Dr. Brian Mueller as Director of Chemistry and Secures Exclusive Ownership of Iodine Extraction Technology - TheNewswire
- 5 months ago - Voyageur Pharmaceuticals Ltd. Strengthens Board of Directors with Seasoned Financial Executive Virginia Alling to Drive U.S. Market Expansion - TheNewswire
- 5 months ago - Voyageur Pharmaceuticals Signs Non-Exclusive Distribution & Wholesale Agreement with PHALANX - TheNewswire
- 1 year ago - Voyageur Clarifies Terms of Previously Announced Agreement - Newsfile Corp